WuXi Biologics announced that WuXi Vaccines, its joint venture with Shanghai Hile Bio-technology, has entered into a strategic partnership with a global vaccine leader and signed a 20-year vaccine manufacturing contract valued approximately $3 billion, pursuant to which WuXi Vaccines will build a dedicated facility and supply commercial vaccine products for the global market. Under the contract, WuXi Vaccines will build an integrated vaccine manufacturing facility including drug substance man...